AOA

AOA Dx

This biotech firm develops non-invasive liquid biopsy tests to provide healthcare providers with early-stage ovarian cancer diagnostics for their patients.

AOA Diagnostics

This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.

Abcodia

The company develops biomarker-based blood tests and algorithms for the early detection of ovarian cancer in high-risk women.

Voc Diagnostics

This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.

Guardant

The company develops blood-based liquid biopsy tests for cancer screening and monitoring for patients and healthcare providers.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Avant Genomics

The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.

PrognomiQ

This healthcare company develops multi-omics blood tests for the early detection and monitoring of cancer and complex diseases for clinical health systems.